Skip to main content
Signal8
Jaiman Manasi profile photo

Manasi Jaiman

CIK: 0002045686

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aardvark Therapeutics, Inc. logo
AARD

Aardvark Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Aardvark Therapeutics, Inc. logo
    AARD

    Aardvark Therapeutics, Inc.

    Feb 9, 2026
    Award(A)

    Stock option (right to buy)

    Direct
    70.5K shares-
  • Aardvark Therapeutics, Inc. logo
    AARD

    Aardvark Therapeutics, Inc.

    Jun 11, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    127K shares-

1-2 of 2

About Jaiman Manasi

Jaiman Manasi (SEC CIK 0002045686) files insider reports with the SEC as Chief Medical Officer of Aardvark Therapeutics, Inc. (AARD).

Signal8 holds 3 ownership filings by Jaiman Manasi (1 Form 3, 2 Form 4), filed between Feb 12, 2025 and Feb 11, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Feb 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jaiman Manasi's filings is in SAN DIEGO, CA.

Recent filings by Jaiman Manasi

  • Feb 9, 2026: Grant or award of AARD derivative securities (Form 4, code A).
  • Jun 11, 2025: Grant or award of AARD derivative securities (Form 4, code A).

Other insiders filing for Aardvark Therapeutics, Inc. (AARD)

How to read Form 4 transaction codes